Mecabamol 750mg Ha Tay tablets treat acute muscle muscle conditions (6 blisters x 10 tablets)

Dosage form Box of 6 blisters x 10 tablets
Specifications Methocarbamol

Ingredient

Composition informationContent
Methocarbamol750mg

Uses

indications

Mecabamol 750 mg Hataphar 6 x 10 is indicated in the following cases: Short -term treatment reduces symptoms of acute muscle muscle diseases related to painful muscle spasms.

Pharmacokic

methocarbamol is a muscle relaxant and has a mild sedative effect. Methocarbamol has a prolonged muscle relaxation effect on the skeletal muscles by selective inhibition on the central nervous system, especially intermediate neurons. Soothe the central nervous system, inhibit shrinkage, relieve central pain, reduce acute pain and muscle spasms. The usual dosage of methocarbamol does not reduce normal muscle as well as muscle reflexes. Methocarbamol does not work directly on the muscle contraction mechanism, motor movement or motor nerve fibers. Methocarbamol at non -toxic doses also works on the nervous system on the upper bone marrow.

Pharmacokinetics

absorption

Methocarbamol is absorbed quickly and almost completely in the digestive tract, appearing in the blood after taking 10 minutes and the peak concentration is about 1-3 hours.

Distribution

Methocarbamol is widely distributed in the kidneys, liver, lungs, brain, spleen, skeletal muscles.

Metabolism

Pharmacological effects come from unchanged pharmaceutical substances and only small percentage is converted into Guaifenesin.

Elimination

The half -life of methocarbamol is 2 hours, quickly excreted and almost completely in the urine. About half of the oral dose is eliminated through the urine within 4 hours, only a small part of which is eliminated in the form of methocarbamol unchanged.

Elderly: The sale time of methocarbamol increases slightly compared to young patients. In addition, the associated ratio with plasma protein decreased slightly (41 - 43% compared to 46 - 50%).

Patients with renal impairment: The clearance of methocarbamol is also reduced by about 40% compared to a normal person.

Patients with liver failure: In patients with secondary cirrhosis of alcoholic cirrhosis, the average total clearance of methocarbamol decreased by about 70% compared to a normal person (11.9 liters/hour) and the selling time lasted for about 3.4 hours. The ratio of methocarbamol attached to plasma proteins is reduced to about 40-45% compared to 46 - 50% of the age and weight of normal people.

Before taking Mecabamol 750mg Ha Tay tablets treat acute muscle muscle conditions (6 blisters x 10 tablets)

How to use

Mecabamol 750 mg Hataphar 6 x 10 is an oral medication.

Dosage

Adults

The starting dose is 2 capsules/time, 4 times/day. The maintenance dose after 2-3 days: about 4 g/day. The dosage can be adjusted with the treatment level achieved 1 tablet/time, 3 times/day.

Elderly

The initial dose is half the maximum dose of adults, which can reduce the sufficient dose to meet the treatment.

Children

Do not take medicine for children.

Patients with liver and kidney failure

Should increase the distance between two medications. Do not overdose recommended.

Treatment time

depends on the symptoms caused by the increase in muscle tone, but not exceeding 30 days.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

Treatment: In case of an overdose, the stomach is to wash, and treat symptoms and support the life function. Maintain appropriate ventilation, monitor the amount of urine and signs of survival, infusion if needed; It is unclear whether the drug is excreted by dialysis.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

Side Effects

When using Mecabamol 750 mg Hataphar 6 x 10, you may experience unwanted effects (ADR).

Common (1/100)

  • Headache.
  • Rare (1/10000 to

  • Headache, dizziness.
  • fever, edema.

    Digestive disorders.

    Hypersensitivity reaction (itching, skin rash, urticaria).

    eye disorders.

  • Conjunctivitis with nasal congestion.
  • Very rare (

  • Nausea and vomiting, nervous system disorders.
  • Sightseeing, drowsiness, tremor, convulsions.
  • Mental disorders.
  • restlessness, anxiety, bewilderment, anorexia.
  • Skin and subcutaneous tissue disorders.

    Other side effects have been reported

  • Blood and lymphatic system: leukopenia, Mach heart disorders, flushing, heartbeat slow, hypotension and fainting.
  • Anaphylactic reaction.

    Gastrointestinal disorders, jaundice (including jaundice).

    Nervous system disorders: dizziness, dementia, grab, vibration of the eyeball, insomnia, convulsions. Skin: Disorders of subcutaneous tissues and especially metal taste.

    Instructions on how to handle ADR

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Mecabamol 750 mg Hataphar 6 x 10 contraindicated in the following cases:

  • Hypersensitivity to the ingredients of the drug.
  • Patients with coma or coma, brain damage, muscle weakness, history of epilepsy.
  • Caution when using

    Patients with liver and kidney failure.

    Drugs should be taken at noon and evening because it can cause drowsiness.

    The ability to drive and operate machinery

    cannot be used.

    Pregnancy

    Because the drug's safety has not been determined during pregnancy, this drug should not be used for pregnant women.

    The period of breastfeeding

    because it is not known whether methocarbamol is in breast milk or not, so it is necessary to use caution for nursing mothers.

    Drug interaction

    methocarbamol may increase the effects of central neurological inhibitors and stimulants including alcohol, barbiturates, anesthetic, anorexia, mental medicine, cholinergic drugs, avoid coordination with.

    methocarbamol inhibits the effects of pyridostigmin bromid should be used cautiously in patients with myasthenia gravis using antacistase drugs.

    Methocarbamol can cause color interference that changes the results of some 5 hydroxyindolacetic acid screening tests (5 - HIAA) using nitrosoaphthol reagent and vanillymandelic screening test (VMA) by gitlow method.

    Storage

    Where dry, temperatures are below 30 ° C.

    Expiry date: 36 months from the date of production. Do not use overdue drugs stated on the packaging.

    Note: When you see the tablet is moldy, colored, the label prints the number of lots, the HD is blurred or there are other suspicious manifestations to bring the medicine to ask the place of sale or the address of the address in the application.

    Manufacturer: Ha Tay Pharmaceutical Joint Stock Company.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords